EUCTR2014-002134-31-IT进行中（未招募）不适用
Evalutation of maraviroc therapy in PI-treated HIV+ patients at intermediate-low risk for cardiovascular diseases: a phase IV, randomized, open study
Ospedale L. Sacco - Azienda Ospedaliera-Polo Universitario0 个研究点开始时间: 2014年10月8日最近更新:
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Stable 2NRTI+PI-based therapy for at least one year
- •VL < 37copies/ml for at least 6 months
- •X5 viral tropism
- •Framingham score 5%
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 30
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 10
排除标准
- •Creatine Clereance <50ml/min
- •GFR < 60 ml/ml
- •Statine therapy
- •tipranavir/ritonavir therapy
- •Immunomodulants treatments in the previous year before the recruitment.
- •Cardiovascular events in the last year
研究者
相似试验
进行中（未招募）
不适用
Virologic efficacy of Maraviroc in adult naive HIV patients with HIV-RNA>= 1000 copies/ml - NDnaive HIV affected patientsMedDRA version: 9.1Level: LLTClassification code 10000811Term: Acute infection with HIVEUCTR2008-006287-11-ITOSPEDALE S. RAFFAELE
进行中（未招募）
不适用
Maraviroc in HIV Acute INfection - NDpatients affected by acute HIV infectionMedDRA version: 9.1Level: LLTClassification code 10000807Term: Acute HIV infectionEUCTR2008-007004-29-ITOSPEDALE S. RAFFAELE
已完成
3 期
Efficacy of Treatment Intensification With Maraviroc on HIV-1 Viral Latency in Recently Infected Hiv-1 naïve Patients Starting Raltegravir Plus Tenofovir/EmtricitabineHIV InfectionsNCT00808002Germans Trias i Pujol Hospital30
进行中（未招募）
不适用
Vicriviroc (SCH 417690) Treatment Protocol in HIV-Infected Subjects: A Substudy of P03802 - NAEUCTR2005-001843-49-DESchering Plough Research Institute80
撤回
4 期
Maraviroc Versus Etravirine In Combination With Antiretroviral Therapy In Drug Experienced HIV And Hepatitis Co-Infected PatientsHuman Immunodeficiency VirusHepatitis C, ChronicHepatitis BNCT00782301ViiV Healthcare